J Hillengass

Publications (1)4.67 Total impact

• Article: Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphoma.

  F McClanahan, T Hielscher, M Rieger, M Hensel, M Bentz, I Schmidt-Wolf, A Käbisch, H Salwender, H Dürk, H Staiger, T Mandel, K Neben, J Hillengass, E Leo, A Krämer, A D Ho, M Witzens-Harig
  American Journal of Hematology 06/2012; 87(10):E68-71. · 4.67 Impact Factor